Pfizer Inc. recalls Buprenorphine Hydrochloride Injection, 0.3 mg base/mL, 1 mL Single-dose Carpuject, Sterile Cartridge Unit with Luer Lock
Recalled July 3, 2024 · FDA recall D-0564-2024 · Pfizer
Hazard
Lack of Assurance of Sterility-The potential for incomplete crimp seals. · FDA Class II
Units
84,710 cartridges
Sold at
US Nationwide and Puerto Rico.
Description
Lack of Assurance of Sterility-The potential for incomplete crimp seals.
Product
Buprenorphine Hydrochloride Injection, 0.3 mg base/mL, 1 mL Single-dose Carpuject, Sterile Cartridge Unit with Luer Lock, For Intramuscular or Intravenous Use, Rx Only, Distributed by Hospira, Inc., Lake Forest, IL 60045 USA. NDC: 0409-2012-03
Manufacturer(s)
Pfizer Inc.
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →